Drospirenone‐containing oral contraceptives and risk of adverse outcomes after myocardial infarction

Conclusion:This is the first study to evaluate the myocardial infarction risk and its subsequent clinical sequelae in women having a STEMI while taking the OC‐Yasmin. Women on the oral contraception Yasmin, who underwent coronary revascularization had a lower post‐procedural complete ST resolution and worse left ventricular function. Furthermore, OC use with Yasmin is an independent predictor of a high‐grade thrombus burden. © 2013 Wiley Periodicals, Inc.

Source: Catheterization and Cardiovascular Interventions - January 30, 2013 Category: Cardiovascular & Thoracic Surgery Authors: Can Yucel Karabay, Gonenc Kocabay, Vecih Oduncu, Arzu Kalayci, Ahmet Guler, Ali Karagöz, Ozkan Candan, Ozcan Basaran, Regayip Zehir, Akın İzgi, Ali Metin Esen, Cevat Kırma Tags: Original Study Source Type: research